Arkolith/Insider Trading/LIPO/Form 4

Kaufman Jonathan H

See remarks below., Director, 10% OwnerLIPELLA PHARMACEUTICALS INC. (LIPO) · full profile →Form 4 · filed Jan 3, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 31, 2024Other(J)12K—$012K
Dec 31, 2024Other(J)43K—$0303K

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001753926-25-000019) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML